Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/7/2024 | $46.00 | Buy → Neutral | Sidoti |
| 2/7/2024 | $38.00 → $46.00 | Market Perform | TD Cowen |
| 11/22/2022 | $44.00 | Hold | Jefferies |
| 7/13/2022 | $43.00 | Neutral → Buy | Sidoti |
| 6/2/2022 | $43.00 | Buy → Neutral | Sidoti |
| 1/31/2022 | $40.00 | Neutral → Buy | Sidoti |
| 11/12/2021 | $14.00 → $13.00 | Buy | Canaccord Genuity |
| 10/14/2021 | $40.00 → $34.00 | Outperform → Market Perform | Cowen & Co. |
LISLE, Ill., Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE:CTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on January 23, 2026, to shareholders of record at the close of business on December 26, 2025. CTS Corporation also announced a new share repurchase program authorizing the company to buy back up to $100 million of its common stock. This program replaces the prior share repurchase program that was approved in February 2024. The program has no set expiration date and allows for repurchases to be made from time to time in the open market or through privately negotiated transact
LISLE, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Kimberly Banks MacKay has been appointed to its Board of Directors, effective November 5, 2025, and that she will serve as a member of the Nominating, Governance and Sustainability Committee, as well as the Technology and Transactions Committee. Ms. MacKay comes to CTS with over 30 years of experience driving results in multi-national companies serving key end markets. Ms. MacKay currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKa
LISLE, Ill., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) announced today that the company will participate in the 17th Annual Southwest IDEAS Conference on November 20, 2025, at The Westin Las Colinas in Dallas, TX. CTS's presentation is scheduled to begin at 4:00 PM Central Time. You may access a live webcast of the event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com. The webcast will also be available for replay on the conference website for one year following the presentation. About CTSCTS (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actu
8-K - CTS CORP (0000026058) (Filer)
10-Q - CTS CORP (0000026058) (Filer)
8-K - CTS CORP (0000026058) (Filer)
4 - CTS CORP (0000026058) (Issuer)
4 - CTS CORP (0000026058) (Issuer)
4 - CTS CORP (0000026058) (Issuer)
Sidoti downgraded CTS Corp from Buy to Neutral and set a new price target of $46.00
TD Cowen reiterated coverage of CTS Corp with a rating of Market Perform and set a new price target of $46.00 from $38.00 previously
Jefferies initiated coverage of CTS Corp with a rating of Hold and set a new price target of $44.00
LISLE, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Kimberly Banks MacKay has been appointed to its Board of Directors, effective November 5, 2025, and that she will serve as a member of the Nominating, Governance and Sustainability Committee, as well as the Technology and Transactions Committee. Ms. MacKay comes to CTS with over 30 years of experience driving results in multi-national companies serving key end markets. Ms. MacKay currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKa
LISLE, Ill., July 01, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) today announced that Mark Pacioni has been appointed Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025. Prior to joining CTS, Mr. Pacioni served as Chief Legal Officer and Secretary of CareerBuilder, LLC from 2019 to 2024 and its successor company, CareerBuilder + Monster, from 2024 until June 2025. Prior thereto, he held senior legal roles at The Boeing Co., Molex, Inc., and Knowles Corp. In addition to his in-house experience, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and was Special Counsel at the U.S. Securities and
LISLE, Ill., Feb. 08, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Amy M. Dodrill has been appointed to its board of directors, effective February 8, 2024, and will serve as a member of the nominating, governance and sustainability and technology and transactions committees. Ms. Dodrill comes to CTS with over 25 years of experience in medical and technology companies and a proven track record of successfully leading and profitably growing global businesses serving key end markets. Ms. Dodrill most recently served as President of Baxter's Global Surgical
LISLE, Ill., Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE:CTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on January 23, 2026, to shareholders of record at the close of business on December 26, 2025. CTS Corporation also announced a new share repurchase program authorizing the company to buy back up to $100 million of its common stock. This program replaces the prior share repurchase program that was approved in February 2024. The program has no set expiration date and allows for repurchases to be made from time to time in the open market or through privately negotiated transact
LISLE, Ill., Oct. 28, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced third quarter 2025 results. "Our business had another quarter of strong growth with sales up 22% year over year in the diversified end markets. The CTS team executed well in a challenging environment achieving solid profitability and strong cash generation," said Kieran O'Sullivan, CEO of CTS Corporation. "Diversification remains a strategic priority to drive growth and margin expansion." Third Quarter 2025 Results Sales were $143 million in the third quarter of 2025, up 8% year-over-yea
LISLE, Ill., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) will release its earnings for the third quarter 2025 at approximately 8:00 a.m. (ET) on Tuesday, October 28, 2025. A conference call to discuss third quarter 2025 results with management is scheduled for Tuesday, October 28, 2025 at 10:00 a.m. (ET). The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-646-844-6383 (Local), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location. The passcode is 815166. A live audio webcast of the conference call will be available and can be accessed directly from the Investo
SC 13G/A - CTS CORP (0000026058) (Subject)
SC 13G - CTS CORP (0000026058) (Subject)
SC 13G/A - CTS CORP (0000026058) (Subject)